QR code

Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The Journal of Infection in Developing Countries 2024-05-01
Reeks:Journal of Infection in Developing Countries
Onderwerpen:
Chronic HCV infection
hepatocellular carcinoma
liver cirrhosis
direct-acting antiviral agents
Online toegang:https://jidc.org/index.php/journal/article/view/18410
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items